|
VIEW THE 50th ANNIVERSARY VIDEO The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties. ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose:
Latest NewsNovember 19, 2024 J&J Sues HHS For Right to Continue its 340B Rebate Model Johnson and Johnson (J&J) sued HHS in district court, asking the court to prevent the agency from acting against its proposed 340B rebate model, and for the court to declare the model lawful. In the lawsuit, J&J claims that HHS’ opposition to the model is “fundamentally at odds with the 340B statute, the Administrative Procedure Act, and HRSA’s own stated program integrity goals.” In the lawsuit, J&J also argued that its model would help mitigate duplicate discounting that would otherwise be in violation of the 340B statute. Under the 340B rebate model that is currently put on hold, J&J had previously sent a notice to 1,200 disproportionate share hospitals that beginning Oct. 15, 2024, it would cease providing 340B discounts to them for Stelara and Xarelto, and that these hospitals would instead need to purchase the drugs at full price and later request a rebate to get the discounted 340B price. [Complaint for Declaratory and Injunctive Relief. Johnson & Johnson Health Care Systems Inc. v. Becerra, U.S. District Court for the District of Columbia, No. 1:24-cv-03188. 12 Nov 2024.]
|
